Cover Image

Open-label phase I clinical trial of Ad5-EBOV in Africans in China

Background: To determine the safety and immunogenicity of a novel recombinant adenovirus type 5 vector based Ebola virus disease vaccine (Ad5-EBOV) in Africans in China. Methods: A phase 1, dose-escalation, open-label trial was conducted. 61 healthy Africans were sequentially enrolled, with 31 parti...

Full description

Saved in:
Bibliographic Details
Main Authors: Lihua Wu (Author), Zhe Zhang (Author), Hainv Gao (Author), Yuhua Li (Author), Lihua Hou (Author), Hangping Yao (Author), Shipo Wu (Author), Jian Liu (Author), Ling Wang (Author), You Zhai (Author), Huilin Ou (Author), Meihua Lin (Author), Xiaoxin Wu (Author), Jingjing Liu (Author), Guanjing Lang (Author), Qian Xin (Author), Guolan Wu (Author), Li Luo (Author), Pei Liu (Author), Jianzhong Shentu (Author), Nanping Wu (Author), Jifang Sheng (Author), Yunqing Qiu (Author), Wei Chen (Author), Lanjuan Li (Author)
Format: Book
Published: Taylor & Francis Group, 2017-09-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items